Pharmaceutical Executive-02-01-2006

Pharmaceutical Executive

Washington Report: Cross-Agency Collaboration for Part D

February 01, 2006

Washington Report

0

0

While CMS officials praise the CED policy as a way to extend Medicare coverage, patients and industry fear the agency won't reimburse for innovative treatments unless sponsors support post-approval studies.

Breath of Hope: TB in Africa

February 01, 2006

Features

0

0

In The Small, Dusty, District Hospital In Temeke, Tanzania, head nurse Sarah Wilson Ochogo is carrying out her morning ritual. She drags a table outside the hospital's tuberculosis (TB) unit, sets out big, white, plastic bottles of pills, and opens a pencil-lined ledger that tracks her patients, their drugs, and their doses. By seven, more than 100 patients are lining up. They place their green patient cards under a stone near the table, and sit down on wooden benches to wait until Ochogo calls their name, gives them their medication, and watches while they take it. By a bit after nine, the patients are off to their daily routines-drawing water, tending crops, or just getting by the way people always have in Africa. And all of them, with luck, are one more day closer to curing their TB.

From the Editor: Terrorism: The Cliff Notes

February 01, 2006

From the Editor

0

0

Is the public ready for an exciting thriller about terrorism, drug counterfeiting, valiant FDA agents, and glamorous women who invite pharma CEOs to come up and look at their drug patents? Sure. Maybe someone should write one.

Opinion: The Media Attacks Ghostwritten Articles

February 01, 2006

Opinion

0

0

Attacking articles in medical journals, those ghostwritten by professional medical writers paid by pharmaceutical companies, is the media's latest attempt to taint anything supported, promoted, or approved by Big Pharma.

Gene Logic: Rescue Squad

February 01, 2006

Company Profile

0

0

Pharma has an enormous backlog of drugs that never made it out of clinical trials. At Gene Logic, these discontinued drugs spell opportunity. Not only are they the foundation of a new business unit at Gene Logic, such failed compounds may become the cornerstone of a new approach to R&D as the industry confronts its latest productivity crisis.

The Five "I"s of Internet Marketing

February 01, 2006

Features

0

0

Online strategies aren't monolithic; each must meet the particular goals of the brand in question, and serve the knowledge needs of a specific disease state. That said, experts agree on many of the fundamentals-the 5 "I"s of Internet marketing:

Leadership: Wake Up Call

February 01, 2006

Leadership

0

0

Corporate leaders' short-sighted focus on EPS and analyst expectations leaves the US workforce far behind its international counterparts when it comes to cultivating innovation. It's time we stepped up to the plate.

Backpage: Taking Hold of the Wheel

February 01, 2006

Columns

0

0

FDA's cautious approach to allowing drug manufacturers to communicate the economic value of drugs is contributing to an already poorly informed healthcare industry, and may be curtailing access to useful drugs.